111 related articles for article (PubMed ID: 36893545)
1. Novel lignans from Zanthoxylum nitidum and antiproliferation activity of sesaminone in osimertinib-resistant non-small cell lung cancer cells.
Wang CY; Qin F; Wang CG; Kim D; Li JJ; Chen XL; Wang HS; Lee SK
Bioorg Chem; 2023 May; 134():106445. PubMed ID: 36893545
[TBL] [Abstract][Full Text] [Related]
2. Undescribed isoquinolines from Zanthoxylum nitidum and their antiproliferative effects against human cancer cell lines.
Qin F; Wang CY; Wang CG; Chen Y; Li JJ; Li MS; Zhu YK; Lee SK; Wang HS
Phytochemistry; 2023 Jan; 205():113476. PubMed ID: 36265658
[TBL] [Abstract][Full Text] [Related]
3. Nitidumpeptins A and B, Cyclohexapeptides Isolated from
Qin F; Wang CY; Kim D; Wang HS; Zhu YK; Lee SK; Yao GY; Liang D
J Org Chem; 2021 Jan; 86(2):1462-1470. PubMed ID: 33410687
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of IRE1α Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells.
Tang ZH; Su MX; Guo X; Jiang XM; Jia L; Chen X; Lu JJ
Anticancer Agents Med Chem; 2018; 18(4):550-555. PubMed ID: 28730963
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of PLOD2 induced osimertinib resistance in non-small cell lung cancer HCC827 cells].
Kang XH; Wang K; Wang Y; Zhao HK; Zhang J; Zhao KL; Miao ZH; Xu ZY; Cao F; Gong YB
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):210-215. PubMed ID: 32252199
[No Abstract] [Full Text] [Related]
6. Bioactive Lignans from Zanthoxylum alatum Roxb. stem bark with cytotoxic potential.
Mukhija M; Lal Dhar K; Nath Kalia A
J Ethnopharmacol; 2014 Feb; 152(1):106-12. PubMed ID: 24412550
[TBL] [Abstract][Full Text] [Related]
7. An Unusual Tetrahydrofuran Lignan from the Roots of Zanthoxylum planispinum and the Potential Anti-inflammatory Effects.
Su GY; Cheng YC; Wang KW; Wang XY; Wu B
Chem Biodivers; 2017 Jan; 14(1):. PubMed ID: 27585089
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of MALAT1 induced osimertinib resistance in HCC827 lung cancer cells].
Kang XH; Gao YY; Wang Y; Cui YH; Zhao KL; Kou WZ; Miao ZH; Cao F; Gong YB
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):257-262. PubMed ID: 31014050
[No Abstract] [Full Text] [Related]
9. Alkaloids from
Wang FF; Tao PF; Zhong YJ; Gu YQ; Wang CY; Qin F
Nat Prod Res; 2024 Apr; ():1-7. PubMed ID: 38684029
[No Abstract] [Full Text] [Related]
10. Thermal treatment decreases resistance to osimertinib in non-small cell lung cancer through the EGFR/PI3K/AKT pathway.
Wang J; Ling X; Zhou M; Ding G; Peng B; Wan J
Neoplasma; 2021 May; 68(3):535-545. PubMed ID: 33724860
[TBL] [Abstract][Full Text] [Related]
11. Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.
Hisakane K; Seike M; Sugano T; Yoshikawa A; Matsuda K; Takano N; Takahashi S; Noro R; Gemma A
Thorac Cancer; 2021 Jun; 12(11):1690-1698. PubMed ID: 33939301
[TBL] [Abstract][Full Text] [Related]
12. Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line.
Tang ZH; Jiang XM; Guo X; Fong CM; Chen X; Lu JJ
Oncotarget; 2016 Dec; 7(49):81598-81610. PubMed ID: 27835594
[TBL] [Abstract][Full Text] [Related]
13. The neurotrophic and antineuroinflammatory effects of phenylpropanoids from Zanthoxylum nitidum var. tomentosum (Rutaceae).
Qin F; Wang FF; Wang CG; Chen Y; Li MS; Zhu YK; Huang XC; Fan CW; Wang HS
Fitoterapia; 2021 Sep; 153():104990. PubMed ID: 34246746
[TBL] [Abstract][Full Text] [Related]
14. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
15. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer.
Yu WB; Chen YC; Huang CY; Ye ZH; Shi W; Zhu H; Shi JJ; Chen J; Lu JJ
Front Med; 2023 Feb; 17(1):105-118. PubMed ID: 36414917
[TBL] [Abstract][Full Text] [Related]
16. MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.
Zhu K; Lv Z; Xiong J; Zheng H; Zhang S; Jin H; Yu L; Li Z; Zhang J; Li C; Liang P
Aging (Albany NY); 2021 Feb; 13(5):6890-6903. PubMed ID: 33621951
[TBL] [Abstract][Full Text] [Related]
17. Coumarins and lignans from Zanthoxylum schinifolium and their anticancer activities.
Li W; Sun YN; Yan XT; Yang SY; Kim EJ; Kang HK; Kim YH
J Agric Food Chem; 2013 Nov; 61(45):10730-40. PubMed ID: 24144361
[TBL] [Abstract][Full Text] [Related]
18. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
19. Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
Zang H; Qian G; Zong D; Fan S; Owonikoko TK; Ramalingam SS; Sun SY
Cancer; 2020 Jan; 126(9):2024-2033. PubMed ID: 31999837
[TBL] [Abstract][Full Text] [Related]
20. Bioactive Constituents of Zanthoxylum rhetsa Bark and Its Cytotoxic Potential against B16-F10 Melanoma Cancer and Normal Human Dermal Fibroblast (HDF) Cell Lines.
Santhanam RK; Ahmad S; Abas F; Safinar Ismail I; Rukayadi Y; Tayyab Akhtar M; Shaari K
Molecules; 2016 May; 21(6):. PubMed ID: 27231889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
